Essence Pharmaceutical (002349.SZ) subsidiary Luhua Senxuan took the lead in formulating an industry standard, which was approved by the National Standards Committee.

Zhichuan Finance APP News, Essence Pharmaceutical (002349.SZ) announced that the industry standard for "1,3-dioxocyclopentane" led by its subsidiary Shandong Luhua Senxuan New Material Co., Ltd. (referred to as "Luhua Senxuan") has passed the review of the National Standards Committee and been announced by the Ministry of Industry and Information Technology. The standard will be officially implemented from March 1, 2026.